inspect molecule / brimonidine tartrate
Brimonidine Tartrate
Brimonidine Tartrate o--o \/ /\ o--o
Brimonidine Tartrate is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.
active moietyBrimonidine Tartrate
administration routeOphthalmic
price comparison status2 snapshots
safety signal rating54 / 100
Adrenergic alpha-Agonists [MoA]openFDA NDC seedopenFDA NDC2 mg/mg
price index
Typical Class Estimates
⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Adrenergic alpha-Agonists [MoA].
$24.50USvsCA$14.20CA
- US Typical Class Average · US$24.50
30 tablets · acquisition-reference · Molecule Index Class Benchmark ↗
- CA Typical Class Average · CACA$14.20
30 tablets · formulary-benefit-price · Molecule Index Class Benchmark ↗
Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.
query trend --id 4949 --12m
Price Trend Index
Deterministic trailing 12-month value delta index for this active ingredient class.
Rising Fast3M: +2.3%12M: +0.1%
Jul 2025Jun 2026
Jan 2026$23.84
Feb 2026$23.67
Mar 2026$23.50
Apr 2026$23.53
May 2026$23.73
Jun 2026$24.03
01 / chemistryIndoco Remedies Limited
Ingredient Breakdown
active moietyBrimonidine Tartrate
formulationOphthalmic Adrenergic alpha-Agonists [MoA]
mechanism of action
Adrenergic alpha-Agonists [MoA]
available strengths
2 mg/mg
02 / ingredientsexcipients
Excipients / Maker Notes
- Not enriched yet from label source.
Manufacturer Notes
- This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals
Steps To Take Safely
- Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
- Read the official label for route-specific directions, contraindications, and storage.
- Ask a clinician or pharmacist before substituting products across countries or formulations.
- Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.
Side-Effect Signals
- label-specific reactions
- allergic reaction
- interaction risk
- dose/formulation confusion
- urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.
$ grep ingredient --same